Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments

Cancer has been the leading cause of mortalities, with lung cancer contributing 18% to overall deaths. Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. The primary form of therapy used to treat lung cancer still includes oral and systemic administration of drugs, radiot...

詳細記述

書誌詳細

出版年:	Pharmaceutics
主要な著者:	Chetna Gupta, Aadya Jaipuria, Nikesh Gupta
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-12-01
主題:	inhalation pulmonary delivery lung cancer dry-powder inhalers nanomedicines
オンライン･アクセス:	https://www.mdpi.com/1999-4923/15/1/139